Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation Dose Intensity Study in Breast Cancer in Young Women: a Randomized Phase III Trial of Additional Dose to the Tumor Bed

NCT00212121 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT00212121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation Dose Intensity Study in Breast Cancer in Young Women: a Randomized Phase III Trial of Additional Dose to the Tumor Bed
Lead sponsor
The Netherlands Cancer Institute
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2004
Completion date
December 31, 2025
Enrollment
2,400 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer